Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11033-11053
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11033
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11033
Table 6 Cut-off values, performance and number of patients per study of Fibroscan®
| Ref. | Cut-off for≥F2 (kPa) | Cut-off for F4 (kPa) | AUC for≥F2 | AUC for F4 | Number of patients included |
| Sandrin et al[147], 2003 | 7.6 | 14.4 | 0.88 | 0.99 | 106 |
| Castéra et al[167], 2005 | 7.1 | 12.5 | 0.83 | 0.95 | 183 |
| Ziol et al[195], 2005 | 8.7 | 14.5 | 0.79 | 0.97 | 327 |
| Kettaneh et al[196], 2007 | 6.8 | 17.6 | 0.79 | 0.91 | 935 |
| Arena et al[197], 2008 | 7.8 | 14.8 | 0.91 | 0.98 | 150 |
| Cross et al[198], 2010 | 8.9 | 10.1 | 0.89 | 0.97 | 187 |
| Degos et al[199], 2010 | 5.2 | 12.9 | 0.75 | 0.90 | 913 |
- Citation: Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11033.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11033